Monoclonal Gammopathy of Uncertain Significance

1

Review clinical trials related to Monoclonal Gammopathy of Uncertain Significance. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

A prospective, pilot study to assess the impact of a 12-month multi-focal lifestyle intervention on myeloma-relevant biomarkers in patients with MGUS or SM. The multimodal lifestyle intervention has six foci that patients will participate in over the course of one-year.

Participants needed: 67
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hackensack Meridian HealthUpdated: Jun 15, 2026
Eligibility criteria

Adults 18 years or older. [+6]

60% or greater clonal plasma cells on bone marrow examination [+9]